While EGFR mutations are drivers of cancer, the function of extracellular domain mutations remains poorly defined. Here, the authors show that the R252C extracellular mutation induces conformational change of EGFR to directly activate ERK and promote cancer growth, which can be targeted by afatinib.
- Yajuan Zhang
- Qizhen Fei
- Weiwei Yang
